Overview
Stage 3 Prostate Cancer is divided into 3 stages called 3A, 3B and 3C. Stage 3 Prostate Cancer refers to a locally advanced cancer, which means the cancer cells have spread from the site in which they were first found.
Understanding your Stage 3 Prostate Cancer diagnosis will help you and your doctors make the best treatment choice for you. Tap “Watch Now” for an easy-to-understand overview of Stage 3 Prostate Cancer.
- Stage 3A Prostate Cancer
- Stage 3B Prostate Cancer
- Stage 3C Prostate Cancer
- Gleason Score & PSA Explained
Overview
Stage 3A Prostate Cancer means that the tumor is affecting one or both sides of the prostate gland as shown here in yellow. It has not spread to your nearby lymph nodes or other organs in your body.
What Tests Will I Need and Why?
Blood and Imaging tests are done to understand your general health, confirm your diagnosis and determine your cancer stage.
Tissue Analysis is done to identify the cancer cell type and the Gleason Score, which is critical to finding the best treatment option for you.
With a Stage 3A Prostate Cancer diagnosis your PSA density is more than 20 and your Gleason Score is at any level. The Gleason Score is used by your doctors to determine the aggressiveness of the cancer.
You may also require special Saliva or Blood Analysis to look for specific mutations (actual changes in your body’s DNA), called BRCA1 and BRCA2.
Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.
Overview
A Stage 3B Prostate Cancer diagnosis means that the tumor has spread to the tissue surrounding your prostate or the glands that produce the fluids that will turn into semen, shown here in yellow. It has not spread to your nearby lymph nodes or to any other organs in your body.
It also means that your PSA can be at any level and any Gleason Score (Grade Group 1-4).
What Tests Will I Need and Why?
Blood and Imaging tests are done to understand your general health, confirm your diagnosis and determine your cancer stage.
Tissue Analysis is done to identify the cancer cell type and the Gleason Score, which is critical to finding the best treatment option for you.
You may also require special Saliva or Blood Analysis to look for specific mutations (actual changes in your body’s DNA), called BRCA1 and BRCA2.
Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.
Overview
A Stage 3C Prostate Cancer diagnosis means that the tumor is located in the prostate only or it is affecting the tissue surrounding the prostate or the glands that produce the fluids that will turn into semen. It has not spread to nearby lymph nodes or other organs.
What Tests Will I Need and Why?
Blood and Imaging tests are done to understand your general health, confirm your diagnosis and determine your cancer stage.
Tissue Analysis is done to identify the cancer cell type and the Gleason Score, which is critical to finding the best treatment option for you.
A Stage 3C diagnosis means that tissue analysis resulted in a Gleason Score of 10 on a scale of 1 to 10. A Gleason Score is used by your doctors to determine the aggressiveness of the cancer.
Stage 3C also means that the PSA can be at any level.
You may also require special Saliva or Blood Analysis to look for specific mutations (actual changes in your body’s DNA), called BRCA1 and BRCA2.
Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.
Gleason Score & PSA Density Explained
A Prostate Cancer diagnosis is based upon the results of staging and two tests called the Gleason Score and the prostate-specific antigen (PSA) tests
Finding Your Gleason Score
Samples of your cancer cells are examined to find out your Gleason Score. A Gleason Score, which will range between 2 and 10, describes how aggressive a prostate tumor is by looking at how similar or different the cancer cells look to healthy cells.
The Gleason Score is made up of 2 grades that range from 1 to 5. A low grade of 1 means that the cells in the tumor look very much like healthy prostate cells. Cells that look completely different to normal cells are assigned a higher score, usually 4 or 5.
- The first grade is given to describe the cells in the largest area of the tumor
- The second grade is given to describe the cells in the second largest area of the tumor.
When these two grades are added together, they give us a Gleason Score between 2 and 10. For example, 3+4 = Gleason Score 7.
Prostate-Specific Antigen (PSA) tests
Your Dr. also measures PSA Density to help determine the aggressiveness of the prostate cancer found. PSA Density is your PSA level, divided by the volume of the prostate gland.
A high PSA density is often a predictor of Prostate Cancer but please discuss your specific situation with your doctors.
Commonly Searched Questions
Early Stage 3 Prostate Cancer Prevention
Specific prevention strategies for Early Stage 3 Prostate Cancer, where the cancer has spread beyond the prostate but is still localized, are not outlined. However, general recommendations to help reduce the risk of prostate cancer include:
• Healthy Diet: Focus on a diet rich in fruits, vegetables, and whole grains. Limit intake of high-fat foods, especially those from animal sources.
• Maintain a Healthy Weight: Achieve and maintain a healthy weight through regular physical activity and a balanced diet.
• Avoid Smoking: Do not smoke and avoid exposure to tobacco smoke.
• Limit Alcohol Consumption: Consume alcohol in moderation or avoid it altogether.
• Regular Screenings: Discuss with your healthcare provider about the benefits of early prostate cancer screenings, especially if you are at higher risk due to family history or other factors.
These general measures aim to lower the risk of developing prostate cancer and support overall health. For personalized recommendations, consulting with a healthcare provider is advised.
Source: Cancer.org
Early Stage 3 Prostate Cancer Definition
Early Stage 3 Prostate Cancer is defined as a stage where the cancer has extended beyond the prostate gland but is still confined to the nearby area. In this stage, cancer cells are present in the seminal vesicles (glands that produce a component of semen) or possibly in the tissues surrounding the prostate. The cancer may have spread into the nearby tissues but has not yet reached distant organs. It is a more advanced stage than Stage 2 but has not progressed to Stage 4, where cancer would have spread to distant parts of the body.
Source: Cancer.org
Early Stage 3 Prostate Cancer Symptoms
Early Stage 3 Prostate Cancer may not always present noticeable symptoms. However, when symptoms do occur, they may include:
• Frequent urination, especially at night
• Difficulty starting or stopping urination
• Weak or interrupted urine flow
• Pain or burning sensation during urination
• Blood in the urine or semen
• Painful ejaculation
It is important to note that these symptoms can also be associated with other conditions, so experiencing them does not necessarily mean one has prostate cancer. Early-stage prostate cancer is often asymptomatic and may be detected through screening tests such as a PSA (prostate-specific antigen) test or a digital rectal exam (DRE).
Source: Cancer.org
Early Stage 3 Prostate Cancer Survival Rate
According to SEER data, the 5-year relative survival rate for Early Stage 3 prostate cancer is approximately 100%. This statistic indicates that nearly all men diagnosed with Stage 3 prostate cancer survive for at least 5 years after diagnosis, though individual outcomes can vary based on factors such as treatment response and overall health.
Source: Cancer.org
Early Stage 3 Prostate Cancer Recurrence Rate
The recurrence rate for early Stage 3 prostate cancer is estimated to be between 30% and 50%. This means that approximately 30% to 50% of men with early Stage 3 prostate cancer may experience a recurrence of the disease after initial treatment. The exact rate can vary based on individual factors, including the specifics of the cancer and the treatments used.
Source: Cancer.org
Early Stage 3 Prostate Cancer Treatment
The treatment options for early Stage 3 prostate cancer typically include Surgery, Radiation Therapy, Active Surveillance, Chemotherapy, Combination Therapy, and other treatments.
Now Click Here To Compare Your Latest Treatment Options.
Source: Cancer.org